Center for Scientific Review; Notice of Closed Meetings

---
identifier: "/us/fr/2013-09579"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Center for Scientific Review; Notice of Closed Meetings"
title_number: 0
title_name: "Federal Register"
section_number: "2013-09579"
section_name: "Center for Scientific Review; Notice of Closed Meetings"
positive_law: false
currency: "2013-04-24"
last_updated: "2013-04-24"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2013-09579"
document_type: "notice"
publication_date: "2013-04-24"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "78 FR 24222"
fr_volume: 78
---


#  Center for Scientific Review; Notice of Closed Meetings

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:* Center for Scientific Review Special Emphasis Panel; R15: Rheumatology, Skeletal Biology, Dental, Muscle, Biomaterial and Tissue Engineering.

*Date:* May 21-22, 2013

*Time:* 8:00 a.m. to 6:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).

*Contact Person:* Aruna K Behera, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4211, MSC 7814, Bethesda, MD 20892, 301-435-6809, *[email protected]* .

*Name of Committee:* Center for Scientific Review Special Emphasis Panel; RFA Panel: Investigations on Primary Immunodeficiency Diseases.

*Date:* May 21, 2013.

*Time:* 12:00 p.m. to 3:00 p.m.

*Agenda:* To review and evaluate grant applications

*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).

*Contact Person:* Scott Jakes, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4198, MSC 7812, Bethesda, MD 20892, 301-495-1506, *[email protected]* .

*Name of Committee:* Center for Scientific Review Special Emphasis Panel; RFA RM-11016: Regional Comprehensive Metabolomics Resource Cores.

*Date:* May 22-23, 2013.

*Time:* 8:30 a.m. to 5:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting).

*Contact Person:* Ping Fan, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5154, MSC 7840, Bethesda, MD 20892, 301-408-9971, *[email protected]* .

*Name of Committee:* Center for Scientific Review Special Emphasis Panel; Mentored Research Scientist Development Award in Metabolomics.

*Date:* May 22, 2013.

*Time:* 12:00 p.m. to 4:00 p.m.

*Agenda:* To review and evaluate grant applications.

*Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting)

*Contact Person:* Allen Richon, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6184, MSC 7892, Bethesda, MD 20892, 301-435-1024, *[email protected]* .

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: April 17, 2013.

David Clary,

Program Analyst, Office of Federal Advisory Committee Policy.